JP2016533346A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016533346A5 JP2016533346A5 JP2016518199A JP2016518199A JP2016533346A5 JP 2016533346 A5 JP2016533346 A5 JP 2016533346A5 JP 2016518199 A JP2016518199 A JP 2016518199A JP 2016518199 A JP2016518199 A JP 2016518199A JP 2016533346 A5 JP2016533346 A5 JP 2016533346A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- cholesterol
- aromatic
- cationic peptide
- phe
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361883513P | 2013-09-27 | 2013-09-27 | |
| US61/883,513 | 2013-09-27 | ||
| PCT/US2014/057826 WO2015048522A1 (en) | 2013-09-27 | 2014-09-26 | Use of aromatic-cationic peptides to treat cholesterol-induced mitochondrial dysfunction |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019021230A Division JP2019104744A (ja) | 2013-09-27 | 2019-02-08 | コレステロール誘発性ミトコンドリア機能不全を治療するための芳香族カチオン性ペプチドの使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016533346A JP2016533346A (ja) | 2016-10-27 |
| JP2016533346A5 true JP2016533346A5 (https=) | 2017-11-09 |
| JP6480921B2 JP6480921B2 (ja) | 2019-03-13 |
Family
ID=52744532
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016518199A Expired - Fee Related JP6480921B2 (ja) | 2013-09-27 | 2014-09-26 | コレステロール誘発性ミトコンドリア機能不全を治療するための芳香族カチオン性ペプチドの使用 |
| JP2019021230A Pending JP2019104744A (ja) | 2013-09-27 | 2019-02-08 | コレステロール誘発性ミトコンドリア機能不全を治療するための芳香族カチオン性ペプチドの使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019021230A Pending JP2019104744A (ja) | 2013-09-27 | 2019-02-08 | コレステロール誘発性ミトコンドリア機能不全を治療するための芳香族カチオン性ペプチドの使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20170057995A1 (https=) |
| EP (1) | EP3049096B1 (https=) |
| JP (2) | JP6480921B2 (https=) |
| CN (1) | CN106102760A (https=) |
| AU (1) | AU2014324705A1 (https=) |
| CA (1) | CA2925475A1 (https=) |
| WO (1) | WO2015048522A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3020393A1 (en) | 2016-04-11 | 2017-10-19 | Carnot, Llc | Chiral peptides |
| CN107320711A (zh) * | 2017-03-24 | 2017-11-07 | 南京大学 | 化合物ss‑31在制备治疗弗里德赖希共济失调及相关疾病药物中的应用 |
| CA3191819A1 (en) * | 2020-09-09 | 2022-03-17 | Hazel Szeto | Methods and compositions for delivery of biotin to mitochondria |
| CN117881411A (zh) | 2021-06-01 | 2024-04-12 | 艾迪雅生物有限责任公司 | 用于眼部药物的延长释放药物递送系统和使用方法 |
| CN114042147B (zh) * | 2021-10-22 | 2023-07-28 | 川北医学院附属医院 | 靶向调控线粒体呼吸链的微纳水凝胶微球及其制备与应用 |
| WO2023230322A1 (en) * | 2022-05-27 | 2023-11-30 | Stealth Biotherapeutics Inc. | Addressing injection site reactions associated with the administration of elamipretide |
| CN115381800B (zh) * | 2022-07-05 | 2023-08-25 | 中国科学院生态环境研究中心 | 一种肝x受体的选择性激动剂及应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2311440A1 (en) | 2001-04-05 | 2011-04-20 | Collagenex Pharmaceuticals, Inc. | Controlled delivery of tetracycline compounds and tetracycline derivatives |
| CA2851972C (en) * | 2004-01-23 | 2015-06-23 | Cornell Research Foundation, Inc. | Methods for reducing oxidative damage |
| CN105031605A (zh) * | 2009-08-12 | 2015-11-11 | 康奈尔大学 | 预防或治疗代谢综合症的方法 |
| WO2013059071A1 (en) * | 2011-10-17 | 2013-04-25 | Cornell University | Aromatic-cationic peptides and uses of same |
| EP3009141A1 (en) * | 2011-12-09 | 2016-04-20 | Stealth Peptides International, Inc. | Aromatic-cationic peptides and uses of same |
-
2014
- 2014-09-26 JP JP2016518199A patent/JP6480921B2/ja not_active Expired - Fee Related
- 2014-09-26 CN CN201480063376.5A patent/CN106102760A/zh active Pending
- 2014-09-26 AU AU2014324705A patent/AU2014324705A1/en not_active Abandoned
- 2014-09-26 US US15/024,757 patent/US20170057995A1/en not_active Abandoned
- 2014-09-26 EP EP14847855.5A patent/EP3049096B1/en not_active Not-in-force
- 2014-09-26 CA CA2925475A patent/CA2925475A1/en not_active Abandoned
- 2014-09-26 WO PCT/US2014/057826 patent/WO2015048522A1/en not_active Ceased
-
2019
- 2019-02-08 JP JP2019021230A patent/JP2019104744A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016533346A5 (https=) | ||
| RU2428428C9 (ru) | Серусодержащие соединения, действующие как ингибиторы сериновой протеазы ns3 вируса гепатита с | |
| WO2020115555A3 (en) | Crf1 receptor antagonist, pharmaceutical formulations and solid forms thereof for the treatment of congenital adrenal hyperplasia | |
| RU2009128653A (ru) | Замещенные циклоалкиламином производные изохинолона | |
| JP2016538271A5 (https=) | ||
| JP2008501637A5 (https=) | ||
| WO2003099195A3 (en) | Immunomodulatory compounds and methods of use thereof | |
| EA201390827A1 (ru) | Применение лаквинимода для уменьшения утомляемости, улучшения функционального состояния и улучшения качества жизни пациентов с рассеянным склерозом | |
| WO2015187542A8 (en) | Histone deacetylase inhibitors and compositions and methods of use thereof | |
| JP2013522367A5 (https=) | ||
| JP2013540776A5 (https=) | ||
| FI3840753T3 (fi) | Migalastaatti käytettäväksi fabryn taudin hoitomenetelmissä potilailla joilla on gla-geenin mutaatio | |
| JP2014527532A5 (https=) | ||
| JP2017222722A5 (https=) | ||
| MX2020010302A (es) | Uso de ácido (1s,3s)-3-amino-4-(difluorometilideno)ciclopentano-1- carboxílico y ácido (s)-3-amino-4-(difluorometilenil)ciclopent-1-e no-1-carboxílico en eltratamiento contra trastornos oculares. | |
| JP2017221201A5 (https=) | ||
| JP2016533392A5 (https=) | ||
| EP4054639A4 (en) | EXON SKIPPING OF FC-EPSILON-RI-BETA AND MS4A6A IN COMBINATION FOR THE TREATMENT OF ALLERGIC DISEASES | |
| EP4259188A4 (en) | PEPTIDE THERAPEUTIC AGENTS FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND RELATED CONDITIONS | |
| AU2024266519A9 (en) | Compositions and methods for the treatment of disorders related to syntaxin-binding protein 1 deficiency | |
| UA88634C2 (en) | Quaternized quinuclidine esters | |
| EP4219534A3 (en) | Methods for treatment of and prophylaxis against inflammatory disorders | |
| JP2016537431A5 (https=) | ||
| CA2838155C (en) | Methods for repairing tissue damage using protease-resistant mutants of stromal cell derived factor-1 | |
| EP2471806A3 (de) | Cyclosporinderivate |